⌘K
Loading ticker…
RenovoRx, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, RenovoRx, Inc. Common Stock (RNXT) has a 3-month relative strength percentile of 18 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 43. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.8%, relative volume 1.76×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
18 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
RNXT is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $1M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $1M |
| VXFVanguard Extended Market ETF | 0.00% | $385K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RNXT Jan avg: 1.66% median: 8.67% win: 75% σ: 25.28% n: 4 2022-04-12 → 2026-05-29 | RNXT Feb avg: 12.47% median: -0.21% win: 50% σ: 46.26% n: 4 2022-04-12 → 2026-05-29 | RNXT Mar avg: -8.44% median: -11.54% win: 25% σ: 18.61% n: 4 2022-04-12 → 2026-05-29 | RNXT Apr avg: -15.78% median: -10.19% win: 0% σ: 14.36% n: 5 2022-04-12 → 2026-05-29 | RNXT May avg: 5.10% median: 6.99% win: 60% σ: 31.56% n: 5 2022-04-12 → 2026-05-29 | RNXT Jun avg: 3.47% median: -0.78% win: 50% σ: 12.37% n: 4 2022-04-12 → 2026-05-29 (current) | RNXT Jul avg: -3.42% median: -3.75% win: 25% σ: 7.76% n: 4 2022-04-12 → 2026-05-29 | RNXT Aug avg: -11.94% median: -16.59% win: 25% σ: 13.65% n: 4 2022-04-12 → 2026-05-29 | RNXT Sep avg: 3.63% median: 0.06% win: 50% σ: 21.14% n: 4 2022-04-12 → 2026-05-29 | RNXT Oct avg: -11.53% median: -12.98% win: 0% σ: 3.85% n: 4 2022-04-12 → 2026-05-29 | RNXT Nov avg: -5.63% median: -2.96% win: 50% σ: 31.47% n: 4 2022-04-12 → 2026-05-29 | RNXT Dec avg: 67.87% median: 11.04% win: 75% σ: 127.20% n: 4 2022-04-12 → 2026-05-29 |